| Anxiety, defence and the elevated plus-maze RJ Rodgers, A Dalvi Neuroscience & Biobehavioral Reviews 21 (6), 801-810, 1997 | 1281 | 1997 |
| Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety RJ Rodgers, NJT Johnson Pharmacology biochemistry and behavior 52 (2), 297-303, 1995 | 948 | 1995 |
| Animal models of anxiety: an ethological perspective RJ Rodgers, BJ Cao, A Dalvi, A Holmes Brazilian journal of medical and biological research 30, 289-304, 1997 | 887 | 1997 |
| Animal models of'anxiety': where next? RJ Rodgers Behavioural pharmacology 8 (6), 477-496, 1997 | 565 | 1997 |
| Anti-obesity drugs: past, present and future RJ Rodgers, MH Tschöp, JPH Wilding Disease models & mechanisms 5 (5), 621-626, 2012 | 553 | 2012 |
| Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety RJ Blanchard, EB Yudko, RJ Rodgers, DC Blanchard Behavioural brain research 58 (1-2), 155-165, 1993 | 460 | 1993 |
| The elevated plus-maze: pharmacology, methodology and ethology RJ Rodgers Ethology and psychopharmacology, 9-44, 1994 | 432 | 1994 |
| Does gut hormone PYY3–36 decrease food intake in rodents? M Tschöp, TR Castaneda, HG Joost, C Thöne-Reineke, S Ortmann, ... Nature 430 (6996), 1-3, 2004 | 316* | 2004 |
| Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice RJ Rodgers, J Haller, A Holmes, J Halasz, TJ Walton, PF Brain Physiology & behavior 68 (1-2), 47-53, 1999 | 314 | 1999 |
| Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice RJ Rodgers, JC Cole Physiology & behavior 54 (4), 729-736, 1993 | 312 | 1993 |
| SB‐334867, a selective orexin‐1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin‐A in rats RJ Rodgers, JCG Halford, RL Nunes de Souza, AL Canto de Souza, ... European Journal of Neuroscience 13 (7), 1444-1452, 2001 | 292 | 2001 |
| Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice RJ Rodgers, JK Shepherd Psychopharmacology 113, 237-242, 1993 | 274 | 1993 |
| Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors RJ Rodgers, JC Cole Physiology & behavior 53 (2), 383-388, 1993 | 254 | 1993 |
| Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test RJ Rodgers, G Perrault, DJ Sanger, G Griebel Pharmacology Biochemistry and Behavior 57 (4), 817-827, 1997 | 247 | 1997 |
| Orexins and appetite regulation RJ Rodgers, Y Ishii, JCG Halford, JE Blundell Neuropeptides 36 (5), 303-325, 2002 | 222 | 2002 |
| Behavioral profile of wild mice in the elevated plus-maze test for anxiety A Holmes, S Parmigiani, PF Ferrari, P Palanza, RJ Rodgers Physiology & behavior 71 (5), 509-516, 2000 | 220 | 2000 |
| Risk assessment and animal models of anxiety DC Blanchard, RJ Blanchard, RJ Rodgers Animal models in psychopharmacology, 117-134, 1991 | 219 | 1991 |
| Responses of Swiss–Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? A Holmes, RJ Rodgers Pharmacology Biochemistry and Behavior 60 (2), 473-488, 1998 | 210 | 1998 |
| Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience RJ Rodgers, C Lee, JK Shepherd Psychopharmacology 106, 102-110, 1992 | 210 | 1992 |
| GABAergic influences on plus-maze behaviour in mice A Dalvi, RJ Rodgers Psychopharmacology 128, 380-397, 1996 | 209 | 1996 |
